Yarrow Bioscience (YARW) EBITDA Margin (2019 - 2026)
Yarrow Bioscience's EBITDA Margin came in at -3096.00% for Q2 2026, up 4440.00 percentage points from -7536.00% a year earlier and up 714.00 percentage points from the prior quarter.
Yarrow Bioscience (YARW) EBITDA Margin (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Yarrow Bioscience reported EBITDA Margin of -4707.77%, up 2097.56 percentage points year-over-year; for FY2025, it came in at -4954.33%, up 3754.85 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -3752.96 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -8709.18% in FY2024 (-1808.71 pp), -6900.47% in FY2023 (-55.87 pp), -6844.60% in FY2022 (-2676.82 pp) and -4167.78% in FY2021 (-2966.40 pp).
- The Q2 2026 figure represents the highest quarterly EBITDA Margin since Q4 2020.
- Year-over-year, EBITDA Margin increased in three of the last four quarters, with an average year-over-year change of +1418.00 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2023 (a gain of 19076.04 percentage points), and the weakest in Q4 2022 (a drop of 24834.75 percentage points).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Yarrow Bioscience | 20.76 Mn | -95.75 Mn | - | -3,096.00% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,096.00% |
| Mar 31, 2026 | -3,810.00% |
| Jun 30, 2025 | -7,536.00% |
| Mar 31, 2025 | -4,550.00% |
| Jun 30, 2024 | -5,198.00% |
| Mar 31, 2024 | -7,380.00% |
| Dec 31, 2023 | -8,989.47% |
| Sep 30, 2023 | -5,468.42% |
| Jun 30, 2023 | -7,642.96% |
| Mar 31, 2023 | -5,875.00% |
| Dec 31, 2022 | -28,065.52% |
| Sep 30, 2022 | -5,486.23% |
| Jun 30, 2022 | -6,567.46% |
| Mar 31, 2022 | -4,857.87% |
| Dec 31, 2021 | -3,230.77% |
| Sep 30, 2021 | -8,074.44% |
| Jun 30, 2021 | -3,225.08% |
| Mar 31, 2021 | -4,230.43% |
| Dec 31, 2020 | -511.01% |
| Sep 30, 2020 | -716.55% |
Yarrow Bioscience EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=YARW&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "YARW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=YARW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();